Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
- PMID: 9419975
- DOI: 10.1038/sj.onc.1201458
Epiregulin binds to epidermal growth factor receptor and ErbB-4 and induces tyrosine phosphorylation of epidermal growth factor receptor, ErbB-2, ErbB-3 and ErbB-4
Abstract
Epiregulin is a member of the epidermal growth factor (EGF) family, and has certain characteristics that are different from that of EGF, including mitogenic responses and binding to EGF receptor (EGFR). Epiregulin may also have another cell surface receptor and/or induces different receptor heterodimerizations for intracellular signaling. We investigated the binding ability of epiregulin to four ErbB family receptors using four human breast carcinoma cell lines that expressed different subsets of receptors. Chemical cross-linking experiments showed that [125I]epiregulin directly bound to each of EGFR and ErbB-4 but not to ErbB-2 and ErbB-3. Furthermore, although epiregulin stimulated tyrosine phosphorylation of all four ErbB receptors, the main intracellular signal was mediated by ErbB-4 and/or EGFR. The pattern of activation of ErbB family receptors was different from that of other EGF-related ligands. Our findings indicate that ErbB-4 and EGFR are receptors for epiregulin, and suggest that EGF-related ligands transduce signals for different biological responses by the hierarchical mechanism.
Similar articles
-
The oncogenic ErbB-2/ErbB-3 heterodimer is a surrogate receptor of the epidermal growth factor and betacellulin.Oncogene. 1998 Mar 12;16(10):1249-58. doi: 10.1038/sj.onc.1201642. Oncogene. 1998. PMID: 9546426
-
Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.Oncogene. 2006 Dec 7;25(58):7565-76. doi: 10.1038/sj.onc.1209740. Epub 2006 Jun 19. Oncogene. 2006. PMID: 16785991
-
Differential heat stress stability of epidermal growth factor receptor and erbB-2 receptor tyrosine kinase activities.J Cell Physiol. 1993 Nov;157(2):237-42. doi: 10.1002/jcp.1041570205. J Cell Physiol. 1993. PMID: 7901224
-
Epidermal growth factor receptor (EGFR) signaling in cancer.Gene. 2006 Jan 17;366(1):2-16. doi: 10.1016/j.gene.2005.10.018. Epub 2005 Dec 27. Gene. 2006. PMID: 16377102 Review.
-
Control of ErbB signaling through metalloprotease mediated ectodomain shedding of EGF-like factors.Growth Factors. 2006 Jun;24(2):121-36. doi: 10.1080/08977190600634373. Growth Factors. 2006. PMID: 16801132 Review.
Cited by
-
Mechanisms and therapeutic targets of ErbB family receptors in hepatocellular carcinoma: a narrative review.Transl Cancer Res. 2024 Jun 30;13(6):3156-3178. doi: 10.21037/tcr-24-837. Epub 2024 Jun 27. Transl Cancer Res. 2024. PMID: 38988928 Free PMC article. Review.
-
Epiregulin is a potent vascular smooth muscle cell-derived mitogen induced by angiotensin II, endothelin-1, and thrombin.Proc Natl Acad Sci U S A. 1999 Feb 16;96(4):1633-8. doi: 10.1073/pnas.96.4.1633. Proc Natl Acad Sci U S A. 1999. PMID: 9990076 Free PMC article.
-
ErbB-4: a receptor tyrosine kinase.Inflamm Res. 2002 Feb;51(2):91-101. doi: 10.1007/BF02684009. Inflamm Res. 2002. PMID: 11926320 Review.
-
Autocrine epiregulin activates EGFR pathway for lung metastasis via EMT in salivary adenoid cystic carcinoma.Oncotarget. 2016 May 3;7(18):25251-63. doi: 10.18632/oncotarget.7940. Oncotarget. 2016. PMID: 26958807 Free PMC article.
-
Differences in genetic signaling, and not mechanical properties of the wall, are linked to ascending aortic aneurysms in fibulin-4 knockout mice.Am J Physiol Heart Circ Physiol. 2015 Jul 1;309(1):H103-13. doi: 10.1152/ajpheart.00178.2015. Epub 2015 May 1. Am J Physiol Heart Circ Physiol. 2015. PMID: 25934097 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous